Institute Of Gastro And Kidney Care Profile
Key Indicators
- Authorised Capital ₹ 50.00 Cr
as on 27-06-2024
- Paid Up Capital ₹ 36.11 Cr
as on 27-06-2024
- Company Age 13 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 103.35 Cr
as on 27-06-2024
- Satisfied Charges ₹ 5.00 Cr
as on 27-06-2024
- Revenue 52.68%
(FY 2023)
- Profit -1887.75%
(FY 2023)
- Ebitda -71.97%
(FY 2023)
- Net Worth -13.84%
(FY 2023)
- Total Assets 9.82%
(FY 2023)
About Institute Of Gastro And Kidney Care
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 50.00 Cr and a paid-up capital of Rs 36.11 Cr.
The company currently has active open charges totaling ₹103.35 Cr. The company has closed loans amounting to ₹5.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Manoranjan Mohapatra, Brundaban Nahak, Subodh Das, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85110OR2011PTC013803
- Company No.
013803
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jun 2011
- Date of AGM
19 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Bhubaneswar, Orissa, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Institute Of Gastro And Kidney Care?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prakash Dalai  | Managing Director | 23-Jun-2011 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manoranjan Mohapatra | Director | 23-Apr-2016 | Current |
| Brundaban Nahak | Director | 23-Jun-2011 | Current |
| Subodh Das | Director | 23-Jun-2011 | Current |
| Sukanto Das | Additional Director | 28-Dec-2022 | Current |
Financial Performance and Corporate Structure Insights of Institute Of Gastro And Kidney Care.
Institute Of Gastro And Kidney Care Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 52.68% increase. The company also saw a substantial fall in profitability, with a 1887.75% decrease in profit. The company's net worth observed a substantial decline by a decrease of 13.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Institute Of Gastro And Kidney Care?
In 2023, Institute Of Gastro And Kidney Care had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Aug 2023 | ₹4.00 M | Open |
Others Creation Date: 04 Mar 2022 | ₹3.50 Cr | Open |
Others Creation Date: 31 Jan 2022 | ₹4.45 Cr | Open |
How Many Employees Work at Institute Of Gastro And Kidney Care?
Institute Of Gastro And Kidney Care has a workforce of 158 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Institute Of Gastro And Kidney Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Institute Of Gastro And Kidney Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
